Millennium Management »

Aslan Pharmaceuticals shares owned by Millennium Management

Quarter-by-quarter ownership of Aslan Pharmaceuticals (ASLN) shares owned by Millennium Management from 13F filings

Historical chart of Millennium Management investment in Aslan Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aslan Pharmaceuticals held by Millennium Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aslan Pharmaceuticals by Millennium Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $42k 80k 0.52
2023-09-30 $149k 81k 1.85
2023-06-30 $510k 140k 3.65
2023-03-31 $548k 189k 2.90

More positions owned by Millennium Management

Ishares Tr Russell 2000 Etf Put Option (IWM)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Microsoft Corporation Put Option (MSFT)
Apple (AAPL)
Amazon Put Option (AMZN)
Meta Platforms Cl A (META)
NVIDIA Corporation Put Option (NVDA)
Tesla Motors Put Option (TSLA)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Ishares Tr Core S&p500 Etf (IVV)
Advanced Micro Devices (AMD)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
salesforce Put Option (CRM)

View all positions for Millennium Management

Top funds holding Aslan Pharmaceuticals

BVF
UBS Group
Citadel Advisors
Shay Capital
Landscape Capital Management
Millennium Management
FNY Investment Advisers
Waterfront Wealth
Ikarian Capital
Schonfeld Strategic Advisors
Jane Street
Onyx Bridge Wealth Group
Capital Analysts
Rhumbline Advisers
Cutler

View all funds holding Aslan Pharmaceuticals